Millendo Therapeutics (Millendo Therapeutics) Accounts Payable : $0.81 Mil (As of Mar. 2021)

View and export this data going back to 2012. Start your Free Trial

What is Millendo Therapeutics Accounts Payable?

Millendo Therapeutics's Accounts Payable for the quarter that ended in Mar. 2021 was $0.81 Mil.

Millendo Therapeutics's quarterly Accounts Payable declined from Sep. 2020 ($1.73 Mil) to Dec. 2020 ($1.49 Mil) and declined from Dec. 2020 ($1.49 Mil) to Mar. 2021 ($0.81 Mil).

Millendo Therapeutics's annual Accounts Payable declined from Dec. 2018 ($2.00 Mil) to Dec. 2019 ($1.50 Mil) and declined from Dec. 2019 ($1.50 Mil) to Dec. 2020 ($1.49 Mil).

Millendo Therapeutics Accounts Payable Historical Data

The historical data trend for Millendo Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Millendo Therapeutics Accounts Payable Chart

Millendo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Accounts Payable

Get a 7-Day Free Trial

2.18

2.24

2.00

1.50

1.49

Millendo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Accounts Payable	Get a 7-Day Free Trial															2.77	1.34	1.73	1.49	0.81

Millendo Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Millendo Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Millendo Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Millendo Therapeutics (Millendo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Millendo Therapeutics Inc (NAS:MLND) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

110 Miller Avenue, Suite 100, Ann Arbor, MI, USA, 48104

Website

https://www.millendo.com

Millendo Therapeutics Inc is a biopharmaceutical company.

Executives

Mary Lynne Hedley	director	C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Howe John P Md	director	C/O BB&T, P O BOX 1250, WINSTON SALEM NC 27102-1250
Carol Giltner Gallagher	director	C/O ATARA BIOTHERAPEUTICS, INC., 3260 BAYSHORE BOULEVARD, BRISBANE CA 94005
Habib J Dable	director	C/O ACCELERON PHARMA INC., 128 SIDNEY STREET, CAMBRIDGE MA 02139
Carole Nuechterlein	director	C/O AVEXIS, INC., 2275 HALF DAY ROAD, SUITE 160, BANNOCKBURN IL 60015
Geoffrey Nichol	director	MEDAREX, 707 STATE ROAD, PRINCETON NJ 08540
James M. Hindman	director	2525 DUPONT DRIVE, IRVINE CA 92612
Christophe Arbet-engels	officer: Chief Medical Officer	C/O MILLENDO THERAPEUTICS, INC., 110 MILLER AVENUE, SUITE 100, ANN ARBOR MI 48104
Ryan Zeidan	officer: Chief Development Officer	C/O MILLENDO THERAPEUTICS, INC., 110 MILLER AVENUE, SUITE 100, ANN ARBOR MI 48104
Julia C. Owens	director, officer: President and CEO	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451
Tamara L Joseph	officer: General Counsel and Secretary	32 GARRISON STREET, APT 50-103, BOSTON MA 02116
Arcudi Iii Louis J	officer: Chief Financial Officer	C/O IDERA PHARMACEUTICALS 167 SYDNEY ST, CAMBRIDGE MA 02139
Randall W Whitcomb	director	10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807
Jeffery M. Brinza	officer: Sec., CAO and General Counsel	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451
Pharis Mohideen	officer: Chief Medical Officer	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451